Cargando…

Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity

Detalles Bibliográficos
Autores principales:	Dogra, Mohit, Singh, Simar Rajan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933870/ https://www.ncbi.nlm.nih.gov/pubmed/33463596 http://dx.doi.org/10.4103/ijo.IJO_3272_20

Ejemplares similares

Commentary: "Indovation" in retinopathy of prematurity management during COVID-19 times
por: Singh, Simar Rajan, et al.
Publicado: (2021)

Commentary: Vitrectomy for stage 4 and 5 retinopathy of prematurity - Selecting the right approach to the vitreous cavity
por: Dogra, Mohit, et al.
Publicado: (2019)

Commentary: Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy
por: Rana, Vipin, et al.
Publicado: (2021)

Commentary: Cardio-ankle vascular index: The how and why for an ophthalmologist
por: Singh, Simar Rajan, et al.
Publicado: (2020)

Commentary: Internal limiting membrane sparing in necrotizing focal retinitis
por: Dogra, Mohit, et al.
Publicado: (2020)

Bilateral iris cysts in an infant with retinopathy of prematurity
por: Singh, Simar Rajan, et al.
Publicado: (2019)

Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity
por: Sindal, Manavi D, et al.
Publicado: (2021)

Commentary: Visual electrophysiology and laboratory-specific normative values – How important are they?
por: Singh, Simar Rajan, et al.
Publicado: (2021)

Commentary: Firework related ocular trauma – Have we learnt our lessons?
por: Tekchandani, Uday, et al.
Publicado: (2021)

Commentary: Role of alpha-2 agonists in regional ophthalmic anaesthesia
por: Singh, Simar Rajan, et al.
Publicado: (2019)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Commentary: Retinal manifestations in patients following COVID-19 infection: A consecutive case series
por: Ayyadurai, Nikitha, et al.
Publicado: (2021)

Commentary: Utility of a smartphone-assisted direct ophthalmoscope camera for a general practitioner in screening of diabetic retinopathy at a primary health care center
por: Markan, Ashish, et al.
Publicado: (2021)

Commentary: Clinical pearls and pitfalls in diagnosing viral anterior uveitis
por: Tekchandani, Uday, et al.
Publicado: (2020)

Commentary: Endophthalmitis and steroids: Important considerations
por: Neupane, Swechya, et al.
Publicado: (2022)

Commentary: Advanced Coats’ disease – Is it worth chasing the goal of globe salvage?
por: Singh, Simar R, et al.
Publicado: (2022)

Commentary: Macular buckling with T-shaped buckle for myopic tractional maculopathy with posterior staphyloma
por: Tekchandani, Uday, et al.
Publicado: (2022)

‘Stop-and-Slide’ technique for trocar insertion during lens-sparing vitrectomy for retinopathy of prematurity
por: Dogra, Mangat Ram, et al.
Publicado: (2020)

Commentary: Systemic versus imaging biomarkers for diabetic macular oedema – Where do we stand?
por: Rana, Vipin, et al.
Publicado: (2021)

Commentary: Biosimilars in the treatment of retinopathy of prematurity
por: Soni, Tanvi, et al.
Publicado: (2023)

Commentary: Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
por: Tekchandani, Uday, et al.
Publicado: (2021)

Safety and efficacy of 532 nm frequency-doubled Nd-YAG green laser photocoagulation for treatment of retinopathy of prematurity
por: Singh, Simar Rajan, et al.
Publicado: (2019)

Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021)

Commentary: Cataract in retinopathy of prematurity - Prevention is the best cure
por: Sen, Parveen, et al.
Publicado: (2022)

Commentary: Parental involvement in retinopathy of prematurity care: An individualized approach
por: Sindal, Manavi D, et al.
Publicado: (2021)

Commentary: Entry sites and access in retinopathy of prematurity surgery: How important are they?
por: Bhende, Pramod S
Publicado: (2020)

Commentary: Predicting need for treatment in retinopathy of prematurity – The elusive Holy Grail
por: Sindal, Manavi D
Publicado: (2022)

Commentary: Deep learning in retinopathy of prematurity: Where do we stand?
por: Sen, Parveen, et al.
Publicado: (2022)

Commentary: Management of central serous chorioretinopathy: Looking beyond the eye
por: Agarwal, Aniruddha, et al.
Publicado: (2018)

Commentary: Retinopathy of prematurity screening made simple – Smartphone-based fundus imaging
por: Panchal, Bhavik
Publicado: (2019)

Impact of the COVID-19 Pandemic on Retinopathy of Prematurity Practice: An Indian Perspective
por: Katoch, Deeksha, et al.
Publicado: (2020)

Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries
por: Dogra, Mangat Ram, et al.
Publicado: (2023)

Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
por: Ratra, Dhanashree
Publicado: (2021)

Commentary: Functional outcome after successful laser for retinopathy of prematurity – Where we stand?
por: Rishi, Ekta, et al.
Publicado: (2019)

Commentary: Knowledge gap among nurses related to retinopathy of prematurity and its prevention and management
por: Walinjkar, Jaydeep Avinash
Publicado: (2021)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
por: Gangwe, Anil, et al.
Publicado: (2021)

Commentary: Publish or perish – Musings of a young faculty
por: Singh, Simar R
Publicado: (2021)

Commentary: Anti-vascular endothelial growth factor therapies in vitreo-retina practice: Biosimilars versus biologics
por: Anantharaman, Giridhar
Publicado: (2021)

Anti-vascular endothelial growth factor therapy in retinopathy of prematurity: An updated literature review
por: Alzuabi, Asma K., et al.
Publicado: (2022)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ee1moqc374nluuao486emnnqnn